Grants and Contributions:

Title:
2223-HQ-000215
Agreement Number:
2223-HQ-000215
Agreement Value:
$1,015,000.00
Agreement Date:
Jul 1, 2022 - Mar 31, 2025
Description:
Not Available
Organization:
Public Health Agency of Canada
Expected Results:

Reduction of turnaround time from sample collection to availability of analysis-ready data;
Increase in production capacity of provincial and territorial laboratories; and
Streamlining and modernization of sharing and integrating data across an established national network.

Location:
Calgary, Alberta, CA T2L 2K8
Reference Number:
1480-2023-2024-Qrt3-0000089
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
892538893
Recipient Type:
Other
Amendment Date
Oct 11, 2023
Recipient's Legal Name:
Alberta Precision Laboratories Ltd.
Program:
National Microbiology Laboratory – Integral Genomics Innovation Program
Program Purpose:

The purpose of this program is to strengthen public health infrastructure in Canada by helping public health laboratories to innovate and scale up genome-sequencing productivity. The program complements existing partnerships by accelerating the speed of genomic sequencing and integrating its outputs within existing public health surveillance activities.

This funding opportunity aims to mobilize public health networks to enhance the generation and availability of genomic information for the detection and tracking of evolution within high consequence pathogens (e.g., COVID-19, tuberculosis, and antimicrobial resistance). The Integral-Innovation Program will improve the timely availability of genomic information on emerging variants and support PHAC's work with provinces, territories, and international partners to improve monitoring, public health surveillance and outbreak response across Canada.

Amendments: